Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

A pretargeted nanoparticle system for tumor cell labeling.

Gunn J, Park SI, Veiseh O, Press OW, Zhang M.

Mol Biosyst. 2011 Mar;7(3):742-8. doi: 10.1039/c005154c. Epub 2010 Nov 24.

2.

Targeted cell uptake of a noninternalizing antibody through conjugation to iron oxide nanoparticles in primary central nervous system lymphoma.

Wang T, Kievit FM, Veiseh O, Arami H, Stephen ZR, Fang C, Liu Y, Ellenbogen RG, Zhang M.

World Neurosurg. 2013 Jul-Aug;80(1-2):134-41. doi: 10.1016/j.wneu.2013.01.011. Epub 2013 Jan 5.

PMID:
23298674
3.

Pretargeting with bispecific fusion proteins facilitates delivery of nanoparticles to tumor cells with distinct surface antigens.

Yang Q, Parker CL, Lin Y, Press OW, Park SI, Lai SK.

J Control Release. 2017 Jun 10;255:73-80. doi: 10.1016/j.jconrel.2017.03.388. Epub 2017 Mar 29.

PMID:
28363519
4.

Preparation of iron oxide-entrapped chitosan nanoparticles for stem cell labeling.

Chaleawlert-Umpon S, Mayen V, Manotham K, Pimpha N.

J Biomater Sci Polym Ed. 2010;21(11):1515-32. doi: 10.1163/092050609X12519805626031. Epub 2010 Jun 9.

PMID:
20537238
5.

Peptide-nanoparticle ligation mediated by cutinase fusion for the development of cancer cell-targeted nanoconjugates.

Galbiati E, Cassani M, Verderio P, Martegani E, Colombo M, Tortora P, Mazzucchelli S, Prosperi D.

Bioconjug Chem. 2015 Apr 15;26(4):680-9. doi: 10.1021/acs.bioconjchem.5b00005. Epub 2015 Mar 13.

PMID:
25741889
6.

Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.

Tassa C, Shaw SY, Weissleder R.

Acc Chem Res. 2011 Oct 18;44(10):842-52. doi: 10.1021/ar200084x. Epub 2011 Jun 10. Review.

7.

The responses of immune cells to iron oxide nanoparticles.

Xu Y, Sherwood JA, Lackey KH, Qin Y, Bao Y.

J Appl Toxicol. 2016 Apr;36(4):543-53. doi: 10.1002/jat.3282. Epub 2016 Jan 28.

PMID:
26817529
8.

Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles.

Cole AJ, David AE, Wang J, Galbán CJ, Yang VC.

Biomaterials. 2011 Sep;32(26):6291-301. doi: 10.1016/j.biomaterials.2011.05.024.

9.

Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.

Chen YC, Chang WH, Wang SJ, Hsieh WY.

J Biomater Sci Polym Ed. 2012;23(15):1903-22. doi: 10.1163/092050611X598329. Epub 2012 May 8.

PMID:
22024467
10.

Tetanus toxin C fragment-conjugated nanoparticles for targeted drug delivery to neurons.

Townsend SA, Evrony GD, Gu FX, Schulz MP, Brown RH Jr, Langer R.

Biomaterials. 2007 Dec;28(34):5176-84. Epub 2007 Sep 14.

11.

Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging.

Lin J, Li Y, Li Y, Wu H, Yu F, Zhou S, Xie L, Luo F, Lin C, Hou Z.

ACS Appl Mater Interfaces. 2015 Jun 10;7(22):11908-20. doi: 10.1021/acsami.5b01685. Epub 2015 May 28.

PMID:
25978458
12.

Targeted nanoparticles assembled via complexation of boronic-acid-containing targeting moieties to diol-containing polymers.

Han H, Davis ME.

Bioconjug Chem. 2013 Apr 17;24(4):669-77. doi: 10.1021/bc300640j. Epub 2013 Mar 18.

13.

Mixed stimuli-responsive magnetic and gold nanoparticle system for rapid purification, enrichment, and detection of biomarkers.

Nash MA, Yager P, Hoffman AS, Stayton PS.

Bioconjug Chem. 2010 Dec 15;21(12):2197-204. doi: 10.1021/bc100180q. Epub 2010 Nov 11.

14.

Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.

Sun C, Fang C, Stephen Z, Veiseh O, Hansen S, Lee D, Ellenbogen RG, Olson J, Zhang M.

Nanomedicine (Lond). 2008 Aug;3(4):495-505. doi: 10.2217/17435889.3.4.495.

15.

Multivalent interactions between streptavidin-based pretargeting fusion proteins and cell receptors impede efficient internalization of biotinylated nanoparticles.

Parker CL, Yang Q, Yang B, McCallen JD, Park SI, Lai SK.

Acta Biomater. 2017 Nov;63:181-189. doi: 10.1016/j.actbio.2017.08.049. Epub 2017 Sep 9.

PMID:
28870833
16.

Role of nanoparticle valency in the nondestructive magnetic-relaxation-mediated detection and magnetic isolation of cells in complex media.

Kaittanis C, Santra S, Perez JM.

J Am Chem Soc. 2009 Sep 9;131(35):12780-91. doi: 10.1021/ja9041077.

17.

Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting.

Cole AJ, David AE, Wang J, Galbán CJ, Hill HL, Yang VC.

Biomaterials. 2011 Mar;32(8):2183-93. doi: 10.1016/j.biomaterials.2010.11.040. Epub 2010 Dec 21.

18.

Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.

Parveen S, Sahoo SK.

Eur J Pharmacol. 2011 Nov 30;670(2-3):372-83. doi: 10.1016/j.ejphar.2011.09.023. Epub 2011 Sep 21. Erratum in: Eur J Pharmacol. 2014 Mar 15;727:186.

PMID:
21951969
19.

Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend.

Zhao J, Mi Y, Liu Y, Feng SS.

Biomaterials. 2012 Feb;33(6):1948-58. doi: 10.1016/j.biomaterials.2011.11.051. Epub 2011 Dec 9.

PMID:
22153869
20.

Surface engineering of iron oxide nanoparticles for targeted cancer therapy.

Kievit FM, Zhang M.

Acc Chem Res. 2011 Oct 18;44(10):853-62. doi: 10.1021/ar2000277. Epub 2011 Apr 29. Review.

Supplemental Content

Support Center